Table 1.

Characteristics of SARS patients

	SARS patients
Number	20
Sex (female/male)	19/1
Age, mean ± s.d. (range) years	32·7 ± 11·7 (21–58)
ICU admission, %	0
Mortality, %	0
Treatment with oral ribavirin
Patient number (%)	20 (100)
Daily dose, mg/kg	50 ± 10·2
Treatment with oral prednisolone
Patient number (%)	20 (100)
Daily dose, mg/kg	1
Treatment with intravenous ribavirin
Patient number (%)	5 (25)
Daily dose, g	1·2
Treatment with intravenous methylprednisolone
Patient number (%)	13 (65)
Daily dose, g	1·3 ± 0·3